Latest California Healthline Stories
An Alzheimer’s ‘Tsunami’ Threatens Latinos
The number of U.S. Latinos with the memory-robbing disease is expected to rise more than eightfold by 2060, to 3.5 million, according to a recent report — putting a strain on families and health care resources.
Travel Ban Spotlights U.S. Dependence On Foreign-Born Doctors
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
Un ‘tsunami’ de Alzheimer amenaza a latinos
Según un informe reciente, se espera que el número de latinos en los Estados Unidos con la enfermedad roba-memoria aumente más de ocho veces para 2060, a 3,5 millones de casos, poniendo presión en las familias y en los recursos de salud.
How Long You Stay On Opioids May Depend On The Doctor You See In the E.R.
A study shows some emergency physicians wrote far more opioid prescriptions and Medicare patients who saw those doctors were more likely to still be taking the addictive painkillers months later.
New Rules Try To Shore Up Individual Health Insurance Market In 2018
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
ER Visits Linked To Falls Spike Among California Seniors
State data show a rise of nearly 40 percent in fall-related visits from 2010 to 2015, a period in which the elderly population grew about 21 percent.
Docs Bill Medicare For End-Of-Life Advice As ‘Death Panel’ Fears Reemerge
The federal program paid $16 million in the first six months of 2016 to counsel 223,000 patients about treatment preferences in their last days.
Influence Of GOP Doctors Caucus Grows As Congress Looks To Replace Health Law
As conservative physicians rise to more powerful positions in government, some question whether they speak for the nation’s doctors.
Rest Of The U.S. Could Learn ‘A Great Deal’ From Covered California, Study Says
Researchers find that the state’s exchange has succeeded by fostering competition, with a large number of insurers in the mix, aggressively negotiating on premiums and setting conditions for health plan participation.
Former FDA Chief Cites 5 Things To Watch On Drug Approvals, And Keeping Drugs Safe
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.